Plasma lipid peroxidation and antioxidant status in patients with oral precancerous lesions and oral cancer
Yadvendra Shahi
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Lucknow, Uttar Pradesh, India
Search for more papers by this authorFahad M. Samadi
Department of Oral Pathology, King George Medical University, Lucknow, Uttar Pradesh, India
Search for more papers by this authorCorresponding Author
Sayali Mukherjee
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Lucknow, Uttar Pradesh, India
Correspondence
Sayali Mukherjee, Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Malhaur (Near Railway Station), Gomti Nagar Extension, Lucknow 226028, Uttar Pradesh, India.
Email: [email protected]; [email protected]
Search for more papers by this authorYadvendra Shahi
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Lucknow, Uttar Pradesh, India
Search for more papers by this authorFahad M. Samadi
Department of Oral Pathology, King George Medical University, Lucknow, Uttar Pradesh, India
Search for more papers by this authorCorresponding Author
Sayali Mukherjee
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Lucknow, Uttar Pradesh, India
Correspondence
Sayali Mukherjee, Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Malhaur (Near Railway Station), Gomti Nagar Extension, Lucknow 226028, Uttar Pradesh, India.
Email: [email protected]; [email protected]
Search for more papers by this authorAbstract
Objective
Oral precancerous lesions like oral leukoplakia and oral submucosal fibrosis are very common in north Indian population which often leads to oral squamous cell carcinoma. Chewing of tobacco, pan masala, and betel nut is very common among north Indian women. Reactive oxygen species (ROS) generation is an important outcome of this habit. Imbalance between ROS and antioxidants leads to oxidative stress. The aim of our study was to determine the level of antioxidants in oral precancerous lesions and oral cancer to predict disease susceptibility.
Method
The study group consisted of 120 subjects among which 25 were with histopathologically confirmed oral cancer, 50 with histopathologically confirmed oral precancerous lesions, and 45 were healthy controls. Blood samples were collected for the evaluation of reduced glutathione (GSH) and antioxidant enzymes, catalase, superoxide dismutase (SOD), glutathione reductase (GR) and oxidative stress markers like malondialdehyde (MDA) and nitrite.
Result
Results demonstrated a decrease in antioxidant enzymes such as catalase, SOD, and GR in oral precancerous lesion and oral cancer from that of healthy control. An increase in reduced glutathione concentration was observed in oral precancerous lesion and oral cancer as compared to healthy control. Malondialdehyde level was increased significantly in oral cancer. Increase in nitrite concentration was not statistically significant in oral precancerous lesion and oral cancer patients as compared to control.
Conclusion
Oxidative stress and antioxidants have been found to be important indicators in oral cancer and in pre-malignant lesions which may predict susceptibility of development of oral cancer.
CONFLICT OF INTEREST
The authors declare that there are no conflicts of interest.
REFERENCES
- 1Chois S, Myers JN. Molecular pathogenesis or oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008; 87: 14–32.
- 2Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893–917.
- 3Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013; 132: 1133–45.
- 4Bentz B. Head and neck squamous cell carcinoma as a model of oxidative-stress and cancer. J Surg Oncol. 2007; 96: 190–1.
- 5Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 2000; 151: 87–95.
- 6Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012; 2012: 1–21.
- 7Buettner GR. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem. 2011; 11: 341–6.
- 8Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007; 35: 1147–50.
- 9Masood N, Malik FA, Kayani MA. Expression of xenobiotic metabolizing genes in head and neck cancer tissues. Asian Pac J Cancer Prev. 2011; 12: 377–82.
- 10Boynton A, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, et al. Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr. 2007; 86: 1445–55.
- 11Aebi H. Catalase in vitro. Meth Enzymol. 1984; 105: 121–6.
- 12Choi HS, Kim JW, Cha YN, Kim C. A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem. 2006; 27: 31–44.
- 13Moron MS, Depierre JW, Mannerwik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophys Acta. 1979; 582: 67–78.
- 14Sheokand S, Kumari A, Sawhney V. Effect of nitric oxide and putrescin on antioxidative responses under NaCl stress in chickpea plants. Physiol Mo Biol Plant. 2008; 14: 355–62.
- 15Nair V, Turner GA. The thiobarbituric acid test for lipid peroxidation: structure of the adduct with malondialdehyde. Lipids. 1984; 19: 804–5.
- 16Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 2008; 440: 361–80.
- 17Beevi SSS, Rasheed AMH, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol. 2004; 34: 379–85.
- 18Arya AK, Pokharia D, Tripathi K. Relationship between oxidative stress and apoptotic markers in lymphocytes of diabetic patients with chronic non healing wound. Diabetes Res Clin Pract. 2011; 94: 377–84.
- 19Manju V, Kalaivani SJ, Nalini N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem. 2002; 35: 621–5.
- 20Tsai JY, Lee MJ, Dah-Tsyr Chang M, Huang H. The effect of catalase on migration and invasion of lung cancer cells by regulating the activities of cathepsin S, L, and K. Exp Cell Res. 2014; 323: 28–40.
- 21Glorieux C, Sandoval JM, Fattaccioli A, Dejeans N, Garbe JC, Dieu M, et al. Chromatin remodeling regulates catalase expression during cancer cells adaptation to chronic oxidative stress. Free Radical Biol Med. 2016; 99: 436–50.
- 22Goh J, Enns L, Fatemie S, Hopkins H, Morton J, Pettan-Brewer C, et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer. 2011; 11: 191.
- 23Metkari SB, Tupkari JV, Barpande SR. An estimation of serum malondialdehyde, superoxide dismutase and vitamin a in oral submucous fibrosis and its clinicopathologic correlation. J Oral Maxillofac Pathol. 2007; 11: 23–7.
10.4103/0973-029X.33960 Google Scholar
- 24Gurudath S, Ganapathy K, D S, Pai A, Ballal S, Ml A. Estimation of superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral leukoplakia and oral cancer - a comparative study. Asian Pac J Cancer Prev. 2012; 13: 4409–12.
- 25Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2005; 9: 361–7.
- 26Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001; 61: 4365–70.
- 27Bafana A, Dutt S, Kumar A, Kumar S, Ahuja PS. The basic and applied aspects of superoxide dismutase. J Mol Catal B Enzym. 2011; 68: 129–38.
- 28Das UN. A radical approach to cancer. Med Sci Monit. 2002; 8: 79–92.
- 29Salzman R, Kankova K, Pacal L, Tomandl J, Horakova Z, Kostrica R. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma. 2007; 54: 321–5.
- 30Glasauer A, Sena LA, Diebold LP, Mazar AP, Chandel NS. Targeting SOD1 reduces experimental non–small-cell lung cancer. J Clin Invest. 2014; 124: 117–28.
- 31Papa L, Hahn M, Marsh EL, Evans BS, Germain D. SOD2 to SOD1 switch in breast cancer. J Biol Chem. 2014; 289: 5412–6.
- 32Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XF. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun. 2014; 5: 3446.
- 33Salem K, Mc Cormick ML, Wendlandt E, Zhan F, Goel A. Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma. Redox Biol. 2015; 4: 23–33.
- 34Zhu Z, Du S, Du Y, Ren J, Ying G, Yan Z. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. J Neurochem. 2018; 144: 93–104.
- 35Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999; 27: 916–21.
- 36Richie JP Jr, Kleinman W, Marina P, Abraham P, Wynder EL, Muscat JE. Blood iron, glutathione, and micronutrient levels and the risk of oral cancer and premalignancy. Nutr Cancer. 2008; 60: 474–82.
- 37Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012; 2012: 1–26.
- 38Liu Y, Li Q, Zhou L, Xie N, Nice EC, Zhang H, et al. Cancer drug resistance: redox resetting renders a way. Oncotarget. 2016; 7: 42740–61.
- 39Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006; 43: 143–81.
- 40Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longevity. 2013; 2013: 1–10.
- 41Zhang Y, Chen SY, Hsu T, Santella M. Immunohistochemical detection of malondialdehyde DNA adducts in human oral mucosa cells. Carcinogenesis. 2002; 23: 207–11.
- 42Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem. 1997; 43: 1209–14.
- 43Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer an precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther. 2010; 6: 487–91.
- 44Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis. 2010; 16: 29–33.
- 45Shilpashree AS, Kumar K, Itagappa M, Ramesh G. Study of oxidative stress and antioxidant status in oral cancer patients. Int J Oral Maxillofac Pathol. 2013; 4: 2–6.
- 46Sahin U, Unlu M, Ozguner MF, Tahan V, Akkaya A. Lipid peroxidation and erythrocyte superoxide dismutase activity in primary lung cancer. Biomed Res. 2001; 12: 13–6.
- 47Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol. 2002; 32: 162–6.
- 48Gitanjali G, Ghalaut V, Rakshak M, Hooda HS. Correlation of lipid peroxidation and alpha-tocopherol supplementation in patients with cervical carcinoma, receiving radical radiotherapy. Gynecol Obstet Invest. 1999; 48: 197–9.
- 49Rasheed MH, Beevi SS, Rajaraman R, Bose SJ. Alleviation of oxidative and nitrosative stress following curative resection in patient with oral cavity cancer. J Surg Oncol. 2007; 96: 194–9.
- 50Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther. 2009; 5: 247–53.
- 51Rasheed MH, Beevi SS, Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol. 2007; 43: 333–8.
- 52Connelly ST, Macabeo-Ong M, Dekker N, Jordon RC, Schmidt BL. Increased nitric oxide levels and iNOS overexpression in oral squamous cell carcinoma. Oral Oncol. 2005; 41: 261–7.
- 53Sangle VA, Chaware SJ, Kulkarni MA, Ingle YC, Singh P, Pooja VK. Elevated tissue nitric oxide in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018; 22: 35–9.
Citing Literature
